These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 7571830)

  • 1. Global programme for control of hepatitis B infection.
    Kane M
    Vaccine; 1995; 13 Suppl 1():S47-9. PubMed ID: 7571830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
    Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
    Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
    Holliday SM; Faulds D
    Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization.
    Maynard JE; Kane MA; Hadler SC
    Rev Infect Dis; 1989; 11 Suppl 3():S574-8. PubMed ID: 2527402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection.
    Mahoney FJ; Woodruff BA; Erben JJ; Coleman PJ; Reid EC; Schatz GC; Kane MA
    J Infect Dis; 1993 Jan; 167(1):203-7. PubMed ID: 8418167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal hepatitis B immunization: infant, and infant plus adolescent immunization.
    Bonanni P
    Vaccine; 1998 Nov; 16 Suppl():S17-22. PubMed ID: 9915027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant and adolescent hepatitis B immunization up to 1999: a global overview.
    Vryheid RE; Kane MA; Muller N; Schatz GC; Bezabeh S
    Vaccine; 2000 Dec; 19(9-10):1026-37. PubMed ID: 11137236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis B virus infection on women and children.
    Shapiro CN; Margolis HS
    Infect Dis Clin North Am; 1992 Mar; 6(1):75-96. PubMed ID: 1533649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S
    Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination--United States, 1982-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(25):549-52, 563. PubMed ID: 12118536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B virus infection in Tonga: identifying high risk groups for immunization with hepatitis B vaccine.
    Wainwright RB; McMahon BJ; Bender TR; Heyward WL; Nakanishi S; Wainwright KY; Foliaki S; Erickson SL; Fields HA
    Int J Epidemiol; 1986 Dec; 15(4):567-71. PubMed ID: 2950066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus: where do we stand and what is the next step for eradication?
    Komatsu H
    World J Gastroenterol; 2014 Jul; 20(27):8998-9016. PubMed ID: 25083074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing strategies for hepatitis B vaccination.
    Alavian SM; Fallahian F; Lankarani KB
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):10-22. PubMed ID: 20061687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.